Probiotic effect on growth and quality of life in children with Cystic Fibrosis

Phase 3

• Conditions: Cystic Fibrosis.; Cystic Fibrosis

• Registration Number: IRCT201205219823N1
• Lead Sponsor: Vice Chancellor of Research, Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 37

Inclusion Criteria

Ages 2 to 12 years old; Cystic Fibrosis disease confirmed by sweat testing, clinical symptoms and common mutations. Exclusion criteria: Patient intolerance to the medication; A lack of parental consent; Inability of probiotic consumption because of severe disease.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of pulmonary exacerbations. Timepoint: One month after the intervention, three months after the intervention. Method of measurement: Review records of patients.;Quality of Life. Timepoint: Before the intervention, three months after the intervention, six months after intervention. Method of measurement: PedsQL 4.0 questionnaire.;Height. Timepoint: Before the intervention, one month after the intervention, three months after the intervention. Method of measurement: Wall of examination room.;Weight. Timepoint: Before the intervention, one month after the intervention, three months after the intervention. Method of measurement: Standard scale.;Head Circumference. Timepoint: Before the intervention, one month after the intervention, three months after the intervention. Method of measurement: Meter.;Arm Circumference. Timepoint: Before the intervention, one month after the intervention, three months after the intervention. Method of measurement: Meter.